Abstract
Harpagophytum procumbens (Devil’s Claw) is a traditional African herbal drug used by the natives of the Kalahari and Savannah desert regions to treat a variety of ailments. In Europe, the anti-inflammatory properties of Harpagophytum procumbens extracts (Hp) have been the basis for its popular use in the treatment of inflammatory disorders of the musculoskeletal system and of low back pain. This is the subject of a draft monograph recently issued by the European drug authorities (EMEA). There is good clinical evidence for Hp’s use in treating painful osteoarthritis, but more evidence (such as from phase-III trials) is needed before Hp can be considered a standard treatment of osteoarthritis and other chronic inflammatory diseases. Here, the published evidence is reviewed that reveal the anti-inflammatory effects of Hp including inhibition of key mediators and promoters of inflammation. The relevance of these effects for the therapeutic use of Hp in osteoarthritis is discussed. The main constituents of Hp, glycosides of harpagoside and of acteoside, have been shown to act on molecular pathways that have become recognised as targets in the development of new anti-inflammatory drugs. The pharmacological profile of Hp is that of a modern anti-inflammatory agent. Today there is great interest in new anti-inflammatory drugs as toxicological doubts have arisen concerning standard drugs but also as it has become apparent that the therapeutic potential of novel anti-inflammatory drugs goes well beyond the treatment of recognised chronic inflammatory diseases. Inflammation is now seen as a primary process in osteoarthritis but also as a key pathophysiological factor in many common modern diseases (cardiovascular disease, diabetes, osteoporosis, neurodegenerative diseases, dementia and Alzheimer’s). The therapeutic potential of Hp, therefore, demands attention.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
McGregor G, Fiebich B, Wartenberg A, Brien S, Lewith G, Wegener T (2005) Phytochem Rev 4:47
ESCOP (2003) Harpagophyti radix – Devil’s Claw Root. European Scientific Cooperative on Phytotherapy, Exeter, UK
EMEA (2008) EMEA/HMPC/476255/07
Brien S, Lewith GT, McGregor G (2006) J Altern Complement Med 12:981
Saxne T, Lindell M, Mansson B, Petersson IF, Heinegard D (2003) Rheumatology (Oxford) 42:903
Ameye LG, Chee WS (2006) Arthritis Res Ther 8:R127
Darlington LG, Ramsey NW (1994) Compr Ther 20:490
Brendler T, Gruenwald J, Ulbricht C, Basch E (2006) J Herb Pharmacother 6:89
WO (2006) 114422
Clarkson C, Staerk D, Hansen SH, Smith PJ, Jaroszewski JW (2006) J Nat Prod 69:1280
Munkombwe NM (2003) Phytochemistry 62:1231
Boje K, Lechtenberg M, Nahrstedt A (2003) Planta Med 69:820
Berger TJ (1987) J Cardiothorac Anesth 1:500
Wenzel P, Wegener T (1995) Deutsche Apotheker Zeitung 135:1131
Whitehouse LW, Znamirowska M, Paul CJ (1983) Can Med Assoc J 129:249
McLeod DW, Revell P, Robinson BV (1979) Br J Pharmacol 66:140P
Eichler O, Koch C (1970) Arzneimittelforschung 20:107
Andersen ML, Santos EH, Seabra Mde L, da Silva AA, Tufik S (2004) J Ethnopharmacol 91:325
Morgenstern E, Pollex S (2000) Phytopharmakaforschung: Poster P18; Abstractband: 92
Lanhers MC, Fleurentin J, Mortier F, Vinche A, Younos C (1992) Planta Med 58:117
Soulimani R, Younos C, Mortier F, Derrieu C (1994) Can J Physiol Pharmacol 72:1532
Catelan SC, Belentani RM, Marques LC, Silva ER, Silva MA, Caparroz-Assef SM, Cuman RK, Bersani-Amado CA (2006) Phytomedicine 13:446
Baghdikian B, Lanhers MC, Fleurentin J, Ollivier E, Maillard C, Balansard G, Mortier F (1997) Planta Med 63:171
Erdos A, Fontaine R, Friehe H, Durand R, Poppinghaus T (1978) Planta Med 34:97
Manez S, Alcaraz MJ, Paya M, Rios JL, Hancke JL (1990) Planta Med 56:656
Abe S, Ishibashi H, Masuo K, Tanaka S-i, Yamaguchi H (2002) Pharmacometrics 62:27
Jadot G, Lecomte A (1992) Lyon Méditerranée médical médecine du sud-est 28:833
O’Neill LA (2006) Nat Rev Drug Discov 5:549
Westacott CI, Sharif M (1996) Semin Arthritis Rheum 25:254
Gunther M, Laufer S, Schmidt PC (2006) Phytochem Anal 17:1
Moussard C, Alber D, Toubin MM, Thevenon N, Henry JC (1992) Prostaglandins Leukot Essent Fatty Acids 46:283
Loew D, Mollerfeld J, Schrodter A, Puttkammer S, Kaszkin M (2001) Clin Pharmacol Ther 69:356
Tippler B, Syrovets T, Loew D, Simmet T (1996) In: Loew D, Rietbrock N (eds) Phytopharmaka II – Forschung und klinische Anwendung, p 96
Benito PB, Lanza AM, Sen AMS, Galindez JDS, Matellano LF, Gomez AS, Martinez MJA (2000) Planta Med 66:324
Jang MH, Lim S, Han SM, Park HJ, Shin I, Kim JW, Kim NJ, Lee JS, Kim KA, Kim CJ (2003) J Pharmacol Sci 93:367
Kundu JK, Mossanda KS, Na H-K, Surh Y-J (2005) Cancer Lett 218:21
Kaszkin M, Beck KF, Koch E, Erdelmeier C, Kusch S, Pfeilschifter J, Loew D (2004) Phytomedicine 11:585
Huang TH, Tran VH, Duke RK, Tan S, Chrubasik S, Roufogalis BD, Duke CC (2006) J Ethnopharmacol 104:149
Fiebich BL, Heinrich M, Hiller KO, Kammerer N (2001) Phytomedicine 8:28
Schulze-Tanzil G, Hansen C, Shakibaei M (2004) Arzneimittelforschung 54:213
Betancor-Fernandez A, Perez-Galvez A, Sies H, Stahl W (2003) J Pharm Pharmacol 55:981
Pan N, Hori H (1996) Redox Rep 2:149
Wang P, Kang J, Zheng R, Yang Z, Lu J, Gao J, Jia Z (1996) Biochem Pharmacol 51:687
Li W, Zheng R, Su B, Jia Z, Li H, Jiang Y, Yao S, Lin N (1996) Int J Radiat Biol 69:481
Herbert JM, Maffrand JP, Taoubi K, Augereau JM, Fouraste I, Gleye J (1991) J Nat Prod 54:1595
Kimura Y, Okuda H, Nishibe S, Arichi S (1987) Planta Med 53:148
Ravn H, Nishibe S, Sasahara M, Xuebo L (1990) Phytochemistry 29:3627
Hayashi K, Nagamatsu T, Ito M, Yagita H, Suzuki Y (1996) Jpn J Pharmacol 70:157
Hayashi K, Nagamatsu T, Ito M, Hattori T, Suzuki Y (1994) Jpn J Pharmacol 66:47
Lee JY, Woo ER, Kang KW (2005) J Ethnopharmacol 97:561
Hausmann M, Obermeier F, Paper DH, Balan K, Dunger N, Menzel K, Falk W, Schoelmerich J, Herfarth H, Rogler G (2007) Clin Exp Immunol 148:373
Ahmad M, Rizwani GH, Aftab K, Ahmad VU, Gilani AH, Ahmad SP (1995) Phytother Res 9:525
Pennacchio M, Syah YM, Alexander E, Ghisalberti EL (1999) Phytother Res 13:254
Costa De Pasquale R, Busa G, Circosta C, Iauk L, Ragusa S, Ficarra P, Occhiuto F (1985) J Ethnopharmacol 13:193
Circosta C, Occhiuto F, Ragusa S, Trovato A, Tumino G, Briguglio F, de Pasquale A (1984) J Ethnopharmacol 11:259
Clarkson C, Campbell WE, Smith P (2003) Planta Med 69:720
Mahomed IM, Ojewole JA (2006) Brain Res Bull 69:57
Gagnier JJ, van Tulder MW, Berman B, Bombardier C (2007) Spine 32:82
Denner SS (2007) Holist Nurs Pract 21:203
Gagnier J, Vantulder M, Berman B, Bombardier C (2006) Cochrane Database Syst Rev:CD004504
Chrubasik S, Kunzel O, Thanner J, Conradt C, Black A (2005) Phytomedicine 12:1
Moher D, Schulz KF, Altman DG (2001) Ann Intern Med 134:657
Gagnier JJ, Boon H, Rochon P, Moher D, Barnes J, Bombardier C (2006) Ann Intern Med 144:364
Unger M, Frank A (2004) Rapid Commun Mass Spectrom 18:2273
Wieland HA, Michaelis M, Kirschbaum BJ, Rudolphi KA (2005) Nat Rev Drug Discov 4:331
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
McGregor, G. (2009). Harpagophytum procumbens – Traditional Anti-inflammatory Herbal Drug with Broad Therapeutic Potential. In: Ramawat, K. (eds) Herbal Drugs: Ethnomedicine to Modern Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-79116-4_6
Download citation
DOI: https://doi.org/10.1007/978-3-540-79116-4_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-79115-7
Online ISBN: 978-3-540-79116-4
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)